Correction to: A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl- XL

The blots of control and docetaxel for caspase-9, caspase-3, caspase-8, Bcl-XL, and tubulin in the Figure 4f were reused from Figure 4 of our previous paper published inJournal of Urology in 2010 (https://doi.org/10.1016/j.juro.2010.07.035).
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research